<?xml version="1.0" encoding="UTF-8" standalone="yes"?><oembed><version><![CDATA[1.0]]></version><provider_name><![CDATA[The Dish]]></provider_name><provider_url><![CDATA[http://dish.andrewsullivan.com]]></provider_url><author_name><![CDATA[Andrew Sullivan]]></author_name><author_url><![CDATA[https://dish.andrewsullivan.com/author/sullydish/]]></author_url><title><![CDATA[The Efficient Private&nbsp;Market]]></title><type><![CDATA[link]]></type><html><![CDATA[
<p>I&#39;m all for it in almost every area. But it does seem to me that, in healthcare, it may generate amazing new drugs and treatments, but it sure doesn&#39;t add up to what we normally think of as <a href="http://theincidentaleconomist.com/wordpress/were-not-good-at-cost-control/" target="_self">market efficiency</a>:</p>
<p><img alt="Spending-vs-GDP-500x554" class="asset  asset-image at-xid-6a00d83451c45669e2014e8904f36c970d" src="https://sullydish.files.wordpress.com/2011/06/6a00d83451c45669e2014e8904f36c970d-550wi.jpg" style="width: 515px;" title="Spending-vs-GDP-500x554" /></p>
<p>Maybe this is just a cultural function of Americans&#39; preference for costly and inefficient medicine over cheaper, more efficient models. But American consumers are usually pretty good at keeping prices in line. In healthcare? For various reasons, it doesn&#39;t seem to work. More on that theme at <a href="http://www.economist.com/node/21518818" target="_self">the <em>Economist</em>.</a></p>
]]></html><thumbnail_url><![CDATA[https://sullydish.files.wordpress.com/2011/06/6a00d83451c45669e2014e8904f36c970d-550wi.jpg?fit=440%2C330]]></thumbnail_url><thumbnail_width><![CDATA[298]]></thumbnail_width><thumbnail_height><![CDATA[330]]></thumbnail_height></oembed>